A not-for-profit company, any surplus income is reinvested for blood cancer patients’ benefit.
Delivery of both academic investigator initiated and industry sponsored clinical trials in haemato-oncology are accelerated with the resource and expertise of ACT and the networks, TAP and IMPACT.
Company Details
- Employees
- 20
- Founded
- 2021
- Address
- Birmingham, West Midlands, Gb
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- http://www.act4patients.com
- Keywords
- Birmingham.
- HQ
- Birmingham, West Midlands
Accelerating Clinical Trials Ltd Questions
Accelerating Clinical Trials Ltd's website is http://www.act4patients.com
Accelerating Clinical Trials Ltd's LinkedIn profile is https://uk.linkedin.com/company/accelerating-clinical-trials-ltd
Accelerating Clinical Trials Ltd has
20 employees.
View email and phone details for 20
employees at Accelerating Clinical Trials Ltd.
Accelerating Clinical Trials Ltd's industry is
Research Services
Accelerating Clinical Trials Ltd's top competitors are
Icon Strategic Solutions,
Anthony Nolan,
Springworks Therapeutics,
Icon Plc,
Blood Cancer Uk,
Didact Foundation,
Mrc Clinical Trials Unit At Ucl,
Eventum Orthopaedics Ltd,
Accelerating Clinical Trials – Accélérer Les Essais Cliniques,
Cure Leukaemia.
Accelerating Clinical Trials Ltd's categories are Research Services
Accelerating Clinical Trials Ltd's founding year is 2021
